Benjamin Mertens
Founder / CEO
Lys Medical
Lys Medical has developed Iriscope, a miniaturized videoendoscopy probe that enables pulmonologists to directly visualize and diagnose peripheral lung nodules with a 93% positive predictive value. This technology significantly reduces the lung cancer patient pathway from several months to just weeks, improving diagnostic efficiency and patient outcomes.
- Healthcare Technology
- Medical Devices
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for diagnosing peripheral lung nodules often involve lengthy patient pathways, sometimes taking months to reach a definitive diagnosis. This delay can negatively impact patient outcomes, particularly in cases of lung cancer where early detection is critical.
Solution
Lys Medical's Iriscope is a miniaturized videoendoscopy probe designed to enable pulmonologists to directly visualize and diagnose peripheral lung nodules. The Iriscope aims to significantly reduce the time required for diagnosis, potentially shortening the patient pathway from months to weeks. By providing real-time direct visualization, the technology facilitates more efficient and accurate diagnoses, leading to improved patient outcomes and streamlined clinical workflows. The device offers a minimally invasive approach to accessing and assessing difficult-to-reach areas of the lung, enhancing diagnostic capabilities.
Target Audience
The primary target audience includes pulmonologists and medical professionals specializing in the diagnosis and treatment of lung diseases, as well as hospitals and care centers focused on improving diagnostic efficiency and patient outcomes in lung cancer.
Features
- Miniaturized videoendoscopy probe for accessing peripheral lung nodules
- Real-time direct visualization of lung tissue
- High positive predictive value (93%) in diagnosing lung nodules
- Minimally invasive procedure